6650--VISN 8 Whole Blood Glucose Monitoring
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
248-NETWORK CONTRACT OFFICE 8 (36C248)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C24826Q0671
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6650
Additional Details
Documents1
The Department of Veterans Affairs, through its Network Contract Office 8 (NCO 8), has issued an award notice for the procurement of whole blood glucose monitoring solutions across VISN 8. This initiative is classified under NAICS code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and is further identified by Product Service Code 6650. The procurement is intended to support the ongoing clinical needs of the Veterans Health Administration within the VISN 8 region, ensuring reliable and accurate blood glucose monitoring for patient care.
The scope of this procurement encompasses the supply of whole blood glucose monitoring products, which are essential for the diagnosis and management of blood glucose levels in patients. The intended outcome is to provide healthcare professionals within VISN 8 with high-quality, dependable diagnostic tools that facilitate effective monitoring and treatment of patients, particularly those with diabetes or related conditions. The deliverables are expected to include in-vitro diagnostic substances and associated supplies that meet stringent federal healthcare standards.
The contracting activity is managed by the 248-Network Contract Office 8, a federal office within the Department of Veterans Affairs. The primary point of contact for this procurement is Paul Jarret, who can be reached via email at [email protected] or by phone at 813-972-2000, extension 3107. The notice remains active as of the posting date, January 7, 2026, and further details, including any attachments, can be accessed through the official SAM.gov opportunity listing.
This procurement is an award notice, indicating that the contract has already been awarded. While specific set-aside requirements or special considerations are not detailed in the notice, the classification under in-vitro diagnostic manufacturing suggests that contractors must be capable of supplying products that comply with federal healthcare regulations and quality standards. The opportunity is particularly relevant for manufacturers and suppliers specializing in diagnostic substances for blood glucose monitoring.
Contractors evaluating this opportunity should note that the primary focus is on the consistent and reliable provision of whole blood glucose monitoring solutions to support the healthcare needs of veterans within the VISN 8 network. The contract is managed at the network level, ensuring centralized oversight and adherence to Department of Veterans Affairs procurement protocols.